Phosphorylation site mutated RB exerts contrasting effects on apoptotic response to different stimuli

Oncogene

Volumn 25, Issue 9, 2006, Pages 1290-1298

  Masselli, A ^a   Wang, J Y J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

p53; Tetracycline regulated gene expression

Indexed keywords

CASPASE; DOXORUBICIN; PHOSPHORYLATION SITE MUTATED RETINOBLASTOMA TUMOR SUPPRESSOR PROTEIN; PROTEIN; STAUROSPORINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CASPASES; CELL CULTURE TECHNIQUES; CELL CYCLE; DOXORUBICIN; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MUTATION; PHOSPHORYLATION; RATS; RETINOBLASTOMA PROTEIN; STAUROSPORINE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 33644775511     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209161     Document Type: Article

References (48)

1. Bosco EE, Mayhew CN, Hennigan RF, Sage J, Jacks T, Knudsen ES. (2004). Nucleic Acids Res 32: 25-34.
2. Boutillier AL, Trinh E, Loeffler JP. (2000). Oncogene 19: 2171-2178.
3. Bremner R, Cohen BL, Sopta M, Hamel PA, Ingles CJ, Gallie BL et al. (1995). Mol Cell Biol 15: 3256-3265.
4. Cauwels A, Janssen B, Waeytens A, Cuvelier C, Brouckaert P. (2003). Nat Immunol 4: 387-393.
5. Chau BN, Borges HL, Chen TT, Masselli A, Hunton IC, Wang JY. (2002). Nat Cell Biol 4: 757-765.
6. Chau BN, Wang JY. (2003). Nat Rev Cancer 3: 130-138.
7. Chen X, Lowe M, Herliczek T, Hall MJ, Danes C, Lawrence DA et al. (2000). J Natl Cancer Inst 92: 1999-2008.
8. Chew YP, Ellis M, Wilkie S, Mittnacht S. (1998). Oncogene 17: 2177-2186.
9. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML et al. (1992). Nature 359: 328-330.
10. Darnell GA, Antalis TM, Johnstone RW, Stringer BW, Ogbourne SM, Harrich D et al. (2003). Mol Cell Biol 23: 6520-6532.
11. Denecker G, Vercammen D, Steemans M, Vanden Berghe T, Brouckaert G, Van Loo G et al. (2001). Cell Death Differ 8: 829-840.
12. Fattman CL, An B, Dou QP. (1997). J Cell Biochem 67: 399-408.
13. Fattman CL, Delach SM, Dou QP, Johnson DE. (2001). Oncogene 20: 2918-2926.
14. Ferguson KL, Slack RS. (2001). Neuroreport 12: A55-62.
15. Gera JF, Fady C, Gardner A, Jacoby FJ, Briskin KB, Lichtenstein A. (1993). J Immunol 151: 3746-3757.
16. Harbour JWaD, DC. (2000). Nature Cell Biol 2: E65-E76.
17. Humphreys DT, Wilson MR. (1999). Cytokine 11: 773-782.
18. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. (1992). Nature 359: 295-300.
19. Knudsen ES, Buckmaster C, Chen TT, Feramisco JR, Wang JY. (1998). Genes Dev 12: 2278-2292.
20. Knudsen ES, Wang JY. (1996). J Biol Chem 271: 8313-8320.
21. Knudsen ES, Wang JY. (1997). Mol Cell Biol 17: 5771-5783.
22. Knudsen KE, Booth D, Naderi S, Sever-Chroneos Z, Fribourg AF, Hunton IC et al. (2000). Mol Cell Biol 20: 7751-7763.
23. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K et al. (1992). Nature 359: 288-294.
24. Lee JO, Russo AA, Pavletich NP. (1998). Nature 391: 859-865.
25. Li K, Li Y, Shelton JM, Richardson JA, Spencer E, Chen ZJ et al. (2000). Cell 101: 389-399.
26. Lin Y, Choksi S, Shen HM, Yang QF, Hur GM, Kim YS et al. (2004). J Biol Chem 279: 10822-10828.
27. Lipinski MM, Jacks T. (1999). Oncogene 18: 7873-7882.
28. Liu ZG, Hsu H, Goeddel DV, Karin M. (1996). Cell 87: 565-576.
29. Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A et al. (2002). Mol Biol Cell 13: 978-988.
30. Mayhew CN, Perkin LM, Zhang X, Sage J, Jacks T, Knudsen ES. (2004). Oncogene 23: 4107-4120.
31. Micheau O, Tschopp J. (2003). Cell 114: 181-190.
32. Mittnacht S. (1998). Curr Opin Genet Dev 8: 21-27.
33. Morgan DO, Fisher RP, Espinoza FH, Farrell A, Nourse J, Chamberlin H et al. (1998). Cancer J Sci Am 4(Suppl 1): S77-S83.
34. Morris EJ, Dyson NJ. (2001). Adv Cancer Res 82: 1-54.
35. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E et al. (2001). Genes Dev 15: 267-285.
36. Nevins JR, Leone G, DeGregori J, Jakoi L. (1997). J Cell Physiol 173: 233-236.
37. Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D et al. (2001). Nature 412: 561-565.
38. Orr MS, Reinhold W, Yu L, Schreiber-Agus N, O'Connor PM. (1998). J Biol Chem 273: 3803-3807.
39. Panaretakis T, Pokrovskaja K, Shoshan MC, Grander D. (2002). J Biol Chem 277: 44317-44326.
40. Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP. (2000). Nat Genet 25: 338-342.
41. Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held-Feindt J et al. (2004). Immunity 21: 415-428.
42. Schnier JB, Nishi K, Goodrich DW, Bradbury EM. (1996). Proc Natl Acad Sci USA 93: 5941-5946.
43. Sever-Chroneos Z, Angus SP, Fribourg AF, Wan H, Todorov I, Knudsen KE et al. (2001). Mol Cell Biol 21: 4032-4045.
44. Siu WY, Yam CH, Poon RY. (1999). FEBS Lett 461: 299-305.
45. Tan X, Martin SJ, Green DR, Wang JY. (1997). J Biol Chem 272: 9613-9616.
46. Tan X, Wang JY. (1998). Trends Cell Biol 8: 116-120.
47. Wagner S, Roemer K. (2005). Biochem Pharmacol 69: 1059-1067.
48. Xiao B, Spencer J, Clements A, Ali-Khan N, Mittnacht S, Broceno C et al. (2003). Proc Natl Acad Sci USA 100: 2363-2368.